LOS ALAMOS, NM,  May 11,  2020 / – Trait Biosciences Inc., a leading biotechnology research organization providing innovative technology to the hemp and cannabis industry, is pleased to announce that Peter J. McDonough, Chief Executive Officer, will be presenting at Canaccord Genuity’s 4th Annual Global Cannabis Conference. The presentation will take place, via webcast, Tuesday, May 12, at 1:20 pm Eastern time (11:20 am Mountain time). McDonough and other company leaders will also be conducting virtual meetings with institutional investors.

A live webcast of McDonough’s presentation can be accessed May 12, via the Canaccord Genuity virtual event site.

About Trait Biosciences

With a team of internationally recognized scientists who are applying best-in-class technology and agricultural science, Trait Biosciences is an emerging biotechnology leader in the hemp and cannabis industries. Its consumer technology platforms provide breakthrough IP and science which produce enhanced cannabinoids featuring predictable onset timing, superior bioavailability, extended stability, and improved taste.  Trait’s patent pending technologies include a process for generating water-soluble cannabinoids that does not rely on emulsion or nanotechnology.  The company’s agricultural technologies increase crop yields and plant safety, including ultrahigh yield Amplified™ plants which dramatically increase a plant’s natural cannabinoid productivity, and its Defence™ RNAi crop protection technology, which eliminates the need for pesticides or fungicides, providing higher quality, safer, CBD-infused nutraceutical and pharmaceutical products. For more information, see www.TraitBio.com.

 

Cautionary Statement on Forward-Looking Information 

Certain information contained in this press release, including any information as to Trait Bioscience Inc.’s (the “Corporation”) strategy, projects, plans or future financial or operating performance, constitutes “forward-looking statements”. All statements, other than statements of historical fact, are forward-looking statements. The words “will”, “expect”, “continue”, “assess”, “anticipate” and similar expressions identify forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions; including material estimates and assumptions that, while considered reasonable by the Corporation as at the date of this press release in light of each of management’s experience and perception of current conditions and expected developments, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements and undue reliance should not be placed on such statements and information.

Any forward-looking statements included in this document are made as of the date of this document and the Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Although management of the Corporation believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.

#   #   #

 Media Contacts

Colleen Rubart

Trait Biosciences

crubart@traitbio.com

+1 (415) 283-7100

 

Thomas Walek

Peaks Strategies

Twalek@PeaksStrategies.com

+1 (917) 353-7575